Clinical trial
Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD) Undergoing Major Abdominal Surgery: A Double-Blind Randomized Control Trial
NCT06230003 is registered in ClinicalTrials.gov with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD) Undergoing Major Abdominal Surgery: A Double-Blind Randomized Control Trial
- Lead sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 21, 2021
- Completion date
- March 1, 2025
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use